Dow Jones

39 134,76

0,77%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
L'Europe
EU
Biocartis Group NV (BCART)
Biocartis Group NV (BCART) Actualités

BCART

Biocartis Group NV (BCART)

Biocartis Group NV

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:EU:BCART

1 2 3 4 5 6 7 8 9 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
09/05/2024	07h00	GlobeNewswire Inc.	Press release Biocartis Group NV: Biocartis Group NV provides an update regarding the publication of its annual report and the annual meeting	EU:BCART	Biocartis Group NV
10/01/2024	23h00	GlobeNewswire Inc.	Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of major shareholdings)	EU:BCART	Biocartis Group NV
10/01/2024	23h00	GlobeNewswire Inc.	Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of large shareholdings)	EU:BCART	Biocartis Group NV
22/11/2023	10h00	GlobeNewswire Inc.	Press release Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion	EU:BCART	Biocartis Group NV
13/11/2023	07h00	GlobeNewswire Inc.	Press release Biocartis NV: Biocartis Hosts Corporate Workshop and Announces Seven Idylla™ Abstracts to be Presented at AMP 2023 Annual Meeting	EU:BCART	Biocartis Group NV
31/10/2023	15h55	GlobeNewswire Inc.	Press release Biocartis Group NV: Announcement regarding Enforcement by Secured Creditors	EU:BCART	Biocartis Group NV
20/10/2023	07h00	GlobeNewswire Inc.	Press release Biocartis Group NV: Four Abstracts Showing Excellent Data for Idylla™ Presented at European Society of Molecular Oncology Congress (ESMO)	EU:BCART	Biocartis Group NV
16/10/2023	07h00	GlobeNewswire Inc.	Press release Biocartis Group NV: Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio	EU:BCART	Biocartis Group NV
12/10/2023	07h00	GlobeNewswire Inc.	Press release Biocartis Group NV: Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations Kit	EU:BCART	Biocartis Group NV
03/10/2023	07h00	GlobeNewswire Inc.	Press Release Biocartis Group NV: Disclosure of transparency notification	EU:BCART	Biocartis Group NV
26/09/2023	07h00	GlobeNewswire Inc.	Press Release Biocartis Group NV: Agreement regarding recapitalization of operating subsidiaries by secured by secured creditors and wind down of listed holding company	EU:BCART	Biocartis Group NV
26/09/2023	07h00	GlobeNewswire Inc.	Press Release Biocartis Group NV: Biocartis announces H1 2023 Results and provides an update on the operational reorganization and recapitalization	EU:BCART	Biocartis Group NV
21/09/2023	07h00	GlobeNewswire Inc.	Press release Biocartis Group NV: Biocartis 2023 half-year results webcast on 26 September 2023	EU:BCART	Biocartis Group NV
28/08/2023	07h00	GlobeNewswire Inc.	Press Release Biocartis Group NV: Biocartis appoints new Medical Advisory Board (MAB) of renowned practice leaders	EU:BCART	Biocartis Group NV
24/08/2023	07h00	GlobeNewswire Inc.	Press Release Biocartis Group NV: Biocartis Announces 2023 Half-Year Results on 26 September 2023	EU:BCART	Biocartis Group NV
10/08/2023	07h00	GlobeNewswire Inc.	Press Release Biocartis Group NV: Biocartis Partners with Lilly to Explore Biomarker Testing for NSCLC Patients using the Idylla™ Platform	EU:BCART	Biocartis Group NV
18/07/2023	07h00	GlobeNewswire Inc.	Press release Biocartis Group NV: Biocartis appoints George Cardoza as new CFO and Head of Service Delivery	EU:BCART	Biocartis Group NV
30/06/2023	07h00	GlobeNewswire Inc.	Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities	EU:BCART	Biocartis Group NV
20/06/2023	17h40	GlobeNewswire Inc.	Press release Biocartis Group NV: Disclosure of transparency notification	EU:BCART	Biocartis Group NV
15/06/2023	17h15	GlobeNewswire Inc.	Press release Biocartis Group NV: Biocartis announces planned operational reorganization and cost reduction program	EU:BCART	Biocartis Group NV
05/06/2023	17h40	GlobeNewswire Inc.	Press release Biocartis Group NV: Biocartis announces resignation CFO	EU:BCART	Biocartis Group NV
12/05/2023	17h40	GlobeNewswire Inc.	Press release Biocartis Group NV: Results of the Annual Shareholders’ Meeting held on 12 May 2023	EU:BCART	Biocartis Group NV
09/05/2023	07h00	GlobeNewswire Inc.	Press release Biocartis Group NV: Biocartis and HiloProbe to Collaborate on Colorectal Cancer Test	EU:BCART	Biocartis Group NV
20/04/2023	07h00	GlobeNewswire Inc.	Press release Biocartis Group NV: Biocartis Reports Results of First Quarter of 2023	EU:BCART	Biocartis Group NV
11/04/2023	22h00	GlobeNewswire Inc.	Press release Biocartis Group NV: Biocartis appoints Roger Moody as new CEO	EU:BCART	Biocartis Group NV
11/04/2023	07h01	GlobeNewswire Inc.	Press release Biocartis Group NV: Invitation to the Annual Shareholders’ Meeting	EU:BCART	Biocartis Group NV
11/04/2023	07h00	GlobeNewswire Inc.	Press release Biocartis Group NV: Biocartis Announces Publication of 2022 Annual Report	EU:BCART	Biocartis Group NV
04/04/2023	07h00	GlobeNewswire Inc.	Press release Biocartis Group NV: Biocartis and APIS Assay Technologies Sign Collaboration to Develop and Commercialise a Breast Cancer Subtyping Test on the Idylla™ platform	EU:BCART	Biocartis Group NV
29/03/2023	07h00	GlobeNewswire Inc.	Press release Biocartis Group NV: Biocartis To Publish 2022 Annual Report on 11 April 2023	EU:BCART	Biocartis Group NV
02/03/2023	07h00	GlobeNewswire Inc.	Press release Biocartis Group NV: Biocartis announces the US FDA 510(k) clearance for the Idylla™ MSI Test	EU:BCART	Biocartis Group NV